
The zzso management of the patient post zzso zzso zzso aims to achieve several zzso Chief among these is to prevent subsequent events, which include death, zzso and zzso Secondary goals include preventing zzso minimizing left zzso zzso zzso and preventing progression to heart zzso This review describes practical zzso for use in the zzso management of the patient post zzso based on American Heart zzso College of zzso zzso The intensity of drug treatment is determined guided by the degree of zzso dysfunction and the presence or absence of zzso and zzso risk zzso All patients post zzso require an zzso zzso zzso inhibitor and zzso therapy, usually with zzso In individuals who cannot tolerate an zzso zzso an zzso zzso blocker zzso is an adequate zzso Numerous studies document the efficacy of zzso zzso which decrease mortality and the risk of heart failure and zzso zzso blockade is recommended long-term for patients post zzso with an zzso ejection fraction zzso or zzso zzso and either symptomatic heart failure or zzso Use of a beta blocker is an important addition to most zzso drug zzso zzso zzso decrease mortality and are especially effective in patients with impaired zzso zzso Among the beta blockers, zzso which also has zzso zzso blocking activity, was found to decrease mortality significantly in patients with low ejection zzso and heart zzso Another drug therapy of value in zzso treatment is use of zzso zzso These are restricted to patients with zzso zzso function in whom congestion is absent and in whom beta zzso are zzso Current guidelines also recommend that patients post zzso with elevated cholesterol levels should be prescribed zzso therapy with a zzso at hospital zzso 

